Single-agent selinixor vs physicians choice in #myelofibrosis | Allessandro Lucchesi, MD | EHA 2025

Single-agent selinixor vs physicians choice in #myelofibrosis | Allessandro Lucchesi, MD | EHA 2025
Optimizing Monitoring After CAR-T Therapy | Manali Kamdar, MD | #EHA2025
Optimizing Monitoring After CAR-T Therapy | Manali Kamdar, MD | #EHA2025
What is the difference between a mini-allo, auto-allo, and haplo-allo transplant?
Blinatumomab in B-cell ALL | Maher Salamoon, MD | #EHA2025
Blinatumomab in B-cell ALL | Maher Salamoon, MD | #EHA2025
What is syngenetic? (the twin type of Allo)
What is Monoclonal Gammopathy of Clinical Significance (MGCS)?
An AI-Assisted Look at Two Platelet-Boosting Drugs | Adrian Mosquera Orgueira, MD | EHA 2025 #AML
An AI-Assisted Look at Two Platelet-Boosting Drugs | Adrian Mosquera Orgueira, MD | EHA 2025 #AML
Treatment of Patients with High-Risk MDS | Maher Salamoon, MD | #EHA2025
Treatment of Patients with High-Risk MDS | Maher Salamoon, MD | #EHA2025
How do you balance graft vs host disease and graft vs myeloma effect?
When should bone marrow biopsies be repeated?
When should bone marrow biopsies be repeated?